ExBRAC - the Pilot Study
NCT06230068 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2025-04-06
Summary
The EXBRAC pilot study will investigate the quality of life of patients with breast cancer, and the effect of an intervention with expressive writing. This is a pilot study with two purposes, the first is to create a questionnaire specifically developed for the ExBRAC study, and the second to evaluate the feasibility of the expressive writing.
Conditions
- Breast Cancer
- Quality of Life
Interventions
- OTHER
-
Expressive writing
See description under arm/group description.
Sponsors & Collaborators
-
Region Skane
lead OTHER
Principal Investigators
-
Linnea Huss, M.D., Ph. D. · Region Skane
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-26
- Primary Completion
- 2025-03-01
- Completion
- 2025-03-01
Countries
- Sweden
Study Locations
More Related Trials
-
Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer
NCT00496288 ·Status: UNKNOWN ·Phase: PHASE2
-
Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer
NCT04021069 ·Status: UNKNOWN
-
A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT01344109 ·Status: WITHDRAWN
-
Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer
NCT00898014 ·Status: COMPLETED
-
MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast Cancer
NCT00978770 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Cohort Study of Breast Cancer Patients Treated With Radiotherapy
NCT04203849 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI
NCT02306538 ·Status: ACTIVE_NOT_RECRUITING
-
Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer
NCT01926964 ·Status: COMPLETED
-
Study of Circulating and Tumor Biomarkers in Breast Cancer Patients
NCT01866202 ·Status: UNKNOWN
-
Hypofractionated Regional Nodal Irradiation in Breast Cancer
NCT06443359 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831
NCT00898898 ·Status: COMPLETED
-
Post Market Study Using the Xoft Axxent System
NCT01017549 ·Status: COMPLETED ·Phase: NA
-
Partial Breast Irradiation in a Low-risk Population Screened With MRI
NCT01255553 ·Status: WITHDRAWN ·Phase: NA
-
Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.
NCT04902937 ·Status: RECRUITING
-
Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer
NCT00438477 ·Status: COMPLETED ·Phase: NA
-
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
NCT02352883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Living Well With Advanced Breast Cancer
NCT07227038 ·Status: RECRUITING
-
The Cardio-Oncology Breast Cancer Study
NCT02571894 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Liquid Crystal Contact Thermography in Detecting Pathological Changes in Female Breasts
NCT03735550 ·Status: UNKNOWN
-
Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation
NCT02348684 ·Status: COMPLETED
-
Internet Use Among Women With Recurrent Metastatic Breast Cancer
NCT00770055 ·Status: COMPLETED ·Phase: NA
-
Comparative Genomic and Genetic Analysis of Paired Primary Breast - Metastatic Tumor Specimens Using High-throughput Platforms
NCT01227733 ·Status: UNKNOWN
-
To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions
NCT03743259 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnostic and Prognostic Value of MicroRNA in Breast Cancer Patients
NCT04778202 ·Status: UNKNOWN
-
MRI and Early Decision-making in Chemotherapy for Breast Cancer
NCT02449824 ·Status: COMPLETED